Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07770841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Name: Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight — clinical trial record (NCT07770841)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OASIS 5

StatusRecruiting

PhasePhase 3

SponsorNovo Nordisk A/S

Started2026-08-12

View on ClinicalTrials.gov ↗

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Results from this study will help select the most optimal lower dose of oral semaglutide that can be used for treating participants living with overweight or obesity.

Trial Details

NCT Number	NCT07770841
Lead Sponsor	Novo Nordisk A/S
Conditions	Overweight, Obesity
Enrollment	450 participants
Start Date	2026-08-12
Primary Completion	2028-02-22 (estimated)
Study Completion	2028-04-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-18